Alberto Malesci Selected Research

Interleukin-6 Receptors (Interleukin 6 Receptor)

11/2020

Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Malesci Research Topics

Disease

17	Neoplasms (Cancer) 10/2021 - 06/2002
12	Inflammation (Inflammations) 03/2024 - 01/2007
12	Crohn Disease (Crohn's Disease) 08/2015 - 01/2007
10	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 07/2007
9	Ulcerative Colitis 10/2022 - 11/2005
9	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 03/2002
4	Carcinogenesis 05/2021 - 03/2002
4	Colitis 11/2017 - 02/2009
3	Pancreatitis 03/2024 - 07/2008
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
3	Microsatellite Instability 12/2020 - 03/2002
3	Hemorrhage 11/2020 - 11/2010
3	Necrosis 06/2012 - 06/2009
3	Deglutition Disorders (Dysphagia) 12/2011 - 03/2010
3	Adenocarcinoma 11/2011 - 12/2007
2	Fistula 01/2023 - 06/2009
2	COVID-19 01/2022 - 11/2020
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 02/2010
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 12/2020 - 01/2012
2	Heartburn (Pyrosis) 02/2012 - 07/2011
2	Gastroesophageal Reflux (GERD) 03/2011 - 01/2010
2	Pathologic Constriction (Stenosis) 11/2010 - 03/2010
1	Dysbiosis 10/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020
1	Infections 11/2020
1	Thrombosis (Thrombus) 11/2020
1	Hemochromatosis (Bronze Diabetes) 03/2020
1	Primitive Neuroectodermal Tumors (PNET) 01/2019
1	Adenoma (Adenomas) 05/2016
1	Pathologic Processes 04/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2013

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2011
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2008
4	AcidsIBA 02/2012 - 03/2011
4	CytokinesIBA 07/2010 - 01/2007
3	IntegrinsIBA 01/2023 - 07/2010
3	Dextrans (Dextran)FDA Link 11/2017 - 07/2008
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2017 - 07/2008
3	Monoclonal AntibodiesIBA 07/2017 - 01/2007
3	SteroidsIBA 12/2011 - 11/2005
3	Proton Pump InhibitorsIBA 07/2011 - 01/2010
3	Infliximab (Remicade)FDA Link 04/2011 - 08/2008
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 09/2013
2	Vitamin D FDA LinkGeneric 01/2022 - 05/2021
2	CalciumIBA 05/2021 - 05/2016
2	Urokinase Plasminogen Activator ReceptorsIBA 10/2016 - 04/2015
2	Codon (Codons)IBA 01/2013 - 06/2002
2	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2013 - 08/2002
2	Protein CIBA 12/2011 - 07/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011 - 01/2007
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2011 - 07/2008
2	Cell Adhesion MoleculesIBA 03/2011 - 02/2009
2	Adalimumab (Humira)FDA Link 01/2011 - 06/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2008 - 01/2008
2	Beclomethasone (Beclometasone)FDA Link 12/2008 - 01/2008
2	Certolizumab Pegol FDA Link 08/2008 - 02/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2024
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	CollagenIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	inter-alpha-inhibitorIBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	CateninsIBA 10/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022
1	MicronutrientsIBA 05/2021
1	Indicators and Reagents (Reagents)IBA 12/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 11/2020
1	tocilizumab (atlizumab)FDA Link 11/2020
1	C-Reactive ProteinIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2020
1	IronIBA 03/2020
1	Free RadicalsIBA 03/2020
1	ElementsIBA 03/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2019
1	OMS 2017IBA 01/2019
1	LipidsIBA 11/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	sym-trinitrobenzeneIBA 10/2016
1	Sulfonic AcidsIBA 10/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2016
1	Peptides (Polypeptides)IBA 10/2016
1	TensinsIBA 02/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2016
1	Messenger RNA (mRNA)IBA 09/2013
1	ThymineIBA 01/2013
1	Calcibiotic Root Canal SealerIBA 01/2013
1	Adenine FDA LinkGeneric 01/2013
1	ral Guanine Nucleotide Exchange FactorIBA 01/2013
1	Cadherins (E-Cadherin)IBA 01/2013
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 06/2012

Therapy/Procedure

16	Therapeutics 01/2022 - 11/2005
4	Stents 11/2010 - 01/2006
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2012
2	Fundoplication 03/2011 - 01/2010
1	Oral Administration 11/2017
1	Duration of Therapy 05/2016
1	Intravenous Injections 04/2014
1	Radiofrequency Ablation 04/2014
1	Endoscopic Hemostasis 01/2013